Organovo
Organovo36About
What does Organovo do?
Organovo Holdings is a pioneering 3D bioprinting company that designs and develops functional three-dimensional human tissue for medical research and therapeutic applications. Founded in 2007, Organovo uses its proprietary NovoGen MMX Bioprinter technology to create human tissue models used in pharmaceutical drug discovery, toxicology testing, and regenerative medicine research. The company's NAMKind™ Human-Based Toxicology Services platform has expanded internationally through distributor partn…
What is Organovo's revenue?
StartupHub estimates Organovo's annual revenue at $17.0M (range $7.0M to $56.5M, 28% confidence), based on comparable companies in the sector.
What is Organovo's valuation?
StartupHub estimates Organovo's effective valuation at $437.1M (range $293.8M to $705.0M, 23% confidence), based on comparable companies in the sector.
How much funding has Organovo raised?
Organovo has raised a total of $118M in funding.
Where is Organovo headquartered?
Organovo is headquartered in San Diego, United States.
When was Organovo founded?
Organovo was founded in 2007.
What industry does Organovo operate in?
Organovo operates in Biotech, Drug Discovery, Regenerative Medicine, Bioprinting, Life Sciences, Healthcare.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 4 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.